Micu, M C; Ostensen, M; Villiger, Peter; Micu, R; Ionescu, R (2018). Paternal exposure to antirheumatic drugs-What physicians should know: Review of the literature. Seminars in arthritis and rheumatism, 48(2), pp. 343-355. Elsevier: 12 months 10.1016/j.semarthrit.2018.01.006
![[img]](https://boris.unibe.ch/style/images/fileicons/text.png) |
Text
1-s2.0-S0049017217307473-main.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (620kB) |
Reproduction capacity and long-term preserved hormonal function are important aspects with big impacts on patients' quality of life. Updated information on the interaction between drug therapy and reproductive function is essential when discussing family planning with patients. Currently, limited data is published regarding paternal exposure to different medications. Thus, it may be a challenge for the practitioner to choose the right therapy for a young male patient. Therefore we reviewed the literature, for effects of antirheumatic drugs on male gonadal function with a focus on spermatogenesis and offspring.
Item Type: |
Journal Article (Review Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Rheumatology and Immunology |
UniBE Contributor: |
Villiger, Peter Matthias |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
0049-0172 |
Publisher: |
Elsevier: 12 months |
Language: |
English |
Submitter: |
Burkhard Möller |
Date Deposited: |
17 Jul 2019 14:35 |
Last Modified: |
05 Dec 2022 15:25 |
Publisher DOI: |
10.1016/j.semarthrit.2018.01.006 |
PubMed ID: |
29502800 |
Uncontrolled Keywords: |
Antirheumatic drugs Biologic therapy DMARDs Fertility Offspring outcome Paternal exposure Pregnancy outcome Sperm parameters |
BORIS DOI: |
10.7892/boris.125129 |
URI: |
https://boris.unibe.ch/id/eprint/125129 |
Actions (login required)
 |
Edit item |